Patterns and significance of concomitant central and peripheral inflammatory demyelination

REFERENCES

• Anderson DW, Ellenberg JH, Leventhal CM, et al. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol 1992; 31: 333–336
   PubMed Web of Science ®Google Scholar
• Beck CA, Metz LM, Svenson LW, et al. Regional variation of multiple sclerosis prevalence in Canada. Mult Scler 2005; 11: 516–519
   PubMed Web of Science ®Google Scholar
• Toyka KV, Gold R. The pathogenesis of CIDP: Rationale for treatment with immunomodulatory agents. Neurology 2003; 60: S2—S7
   PubMed Web of Science ®Google Scholar
• McLeod JG, Pollard JD, Macaskil I P, et al. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999; 46: 910–913
   PubMed Web of Science ®Google Scholar
• Mygland A, Monstad P. Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol 2001; 8: 157–165
   PubMed Web of Science ®Google Scholar
• Miglietta 0, Lowenthal M. A study of peripheral nerve involve-ment in fifty-four patients with multiple sclerosis. Arch Phys Med Rehabil 1961; 42: 573–578
   PubMedGoogle Scholar
• Striihuber A. iibet. Regenerations- und Proliferationsvorghge bei multipler Sklerose des Nervensystems. Beitr Pathol Anat 1903; 33: 409–412
   Google Scholar
• Dinkler. Zur Kasuistik der multiplen Herdsklerose des Gehirns und Rückenmarks. D Zeitschr Nervenheilkunde 1904; 26: 233–247
   Google Scholar
• Schob F. Ein Beitrag fur pathologischen Anatomic der Multiplen Sklerose. Monatsschr Psychiatr Neurol 1907; 22: 62–73
   Google Scholar
• Schoene WC, Carpenter S, Behan PO, et al. ‘Onion bulb’ formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuro-pathy. Brain 1977; 100: 755–773
   PubMed Web of Science ®Google Scholar
• Hasson J, Terry RD, Zimmerman HM. Peripheral neuropathy in multiple sclerosis. Neurology 1958; 8: 503–510
   PubMed Web of Science ®Google Scholar
• Pollock M, Calder C, Allpress S. Peripheral nerve abnormality in multiple sclerosis. Ann Neurol 1977; 2: 41–48
   PubMed Web of Science ®Google Scholar
• Shefner JM, Carter JL, Krarup C. Peripheral sensory abnormalities in patients with multiple sclerosis. Muscle Nerve 1992; 15: 73–76
   PubMed Web of Science ®Google Scholar
• Eisen A, Paty D, Hoirch M. Altered supernormality in multiple sclerosis peripheral nerve. Muscle Nerve 1982; 5: 411–414
   PubMed Web of Science ®Google Scholar
• Weir A, Hansen S, Ballantyne JP. Single fibre electromyographic jitter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1979; 42: 1146–1150
   PubMed Web of Science ®Google Scholar
• Grana EA, Kraft GH. Electrodiagnostic abnormalities in patients with multiple sclerosis. Arch Phys Med Rehabil 1994; 75: 778–782
   PubMed Web of Science ®Google Scholar
• Symond CP, Blackwood W. Spinal cord compression in hypertrophic neuritis. Brain 1962; 85: 251–262
   Web of Science ®Google Scholar
• Thomas PK, Walker RW, Rudge P, et al. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain 1987; 110 (Pt 1): 53–76
   PubMedGoogle Scholar
• Mendell JR, Kolkin S, Kissel JT, et al. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1987; 37: 1291–1294
   PubMed Web of Science ®Google Scholar
• Ormerod IE, Waddy HM, Kermode AG, et al. Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: A clinical, electrophysiological and magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 1990; 53: 789–793
   PubMed Web of Science ®Google Scholar
• Ohtake T, Komori T, Hirose K, et al. CNS involvement in Japanese patients with chronic inflammatory demyelinating polyradiculoneuropathy. Acta Neurol Scand 1990; 81: 108–112
   PubMed Web of Science ®Google Scholar
• Ferbert A, Thron A. MRI lesions in younger healthy adults. J Neurol Neurosurg Psychiatry 1992; 55: 246
   PubMed Web of Science ®Google Scholar
• Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988; 38: 1822–1825
   PubMed Web of Science ®Google Scholar
• Feasby TE, Hahn AF, Koopman WJ, et al. Central lesions in chronic inflammatory demyelinating polyneuropathy: An MRI study. Neurology 1990; 40: 476–478
   PubMed Web of Science ®Google Scholar
• Laura M, Leong W, Murray NM, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cord. Neurology 2005; 64: 914–916
   PubMed Web of Science ®Google Scholar
• Waxman SG. Peripheral nerve abnormalities in multiple sclerosis. Muscle Nerve 1993; 16: 1–5
   PubMed Web of Science ®Google Scholar
• Pakalnis A, Drake ME, Jr, Barohn RJ, et al. Evoked potentials in chronic inflammatory demyelinating polyneuropathy. Arch Neurol 1988; 45: 1014–1016
   PubMedGoogle Scholar
• Uncini A, Gallucci M, Lugaresi A, et al. CNS involvement in chronic inflammatory demyelinating polyneuropathy: An electro-physiological and MRI study. Electromyogr Clin Neurophysiol 1991; 31: 365–371
   PubMedGoogle Scholar
• Stojkovic T, de Seze J, Hurtevent JF, et al. Visual evoked potentials study in chronic idiopathic inflammatory demyelinat-ing polyneuropathy. Clin Neurophysiol 2000; 111: 2285–2291
   PubMed Web of Science ®Google Scholar
• Gigli GL, Carlesimo A, Valente M, et al. Evoked potentials suggest cranial nerves and CNS involvement in chronic relapsing polyradiculoneuropathy. Eur Neurol 1989; 29: 145–149
   PubMed Web of Science ®Google Scholar
• Feeney DJ, Pollard JD, McLeod JG, et al. HLA antigens in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1990; 53: 170–172
   PubMed Web of Science ®Google Scholar
• Hawkins SA, Cullen C, Middleton D, et al. HLA antigens and multiple sclerosis in Northern Ireland. kJ Med Sci 1990; 159: 68–70
   Google Scholar
• McDonald WI. Multiple sclerosis: Epidemiology and HLA associations. Ann N Y Acad Sci 1984; 436: 109–117
   PubMed Web of Science ®Google Scholar
• Koller H, Kieseier BC, Jander S, et al. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 2005; 352: 1343–1356
   PubMed Web of Science ®Google Scholar
• Kieseier BC, Dalakas MC, Hartung HP. Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology 2002; 59: S7—S12
   PubMed Web of Science ®Google Scholar
• Hemmer B, Kieseier B, Cepok S, et al. New immunopathologic insights into multiple sclerosis. Curr Neurol Neurosci Rep 2003; 3: 246–255
   PubMedGoogle Scholar
• Lassmann H, Bruck W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: Implications for diagnosis and therapy. Trends Mol Med 2001; 7: 115–121
   PubMed Web of Science ®Google Scholar
• Rezania K, Gundogdu B, Soliven B. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. Front Biosci 2004; 9: 939–945
   PubMed Web of Science ®Google Scholar
• McMahon EJ, Bailey SL, Castenada CV, et al. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 2005; 11: 335–339
   PubMed Web of Science ®Google Scholar
• Gamstorp I. Encephalo-myelo-radiculo-neuropathy: Involvement of the CNS in children with Guillain-Barre-Strohl syndrome. Dey Med Child Neurol 1974; 16: 654–658
   PubMed Web of Science ®Google Scholar
• Green SH. Polyradiculitis (Landry-Guillain-Barre syndrome) with total external ophthalmoplegia: Encephalo-myelo-radiculo-neuropathy. Dey Med Child Neurol 1976; 18: 369–373
   PubMed Web of Science ®Google Scholar
• Lassmann H, Budka H, Schnaberth G. Inflammatory demyelinat-ing polyradiculitis in a patient with multiple sclerosis. Arch Neurol 1981; 38: 99–102
   PubMed Web of Science ®Google Scholar
• Best PV. Acute polyradiculoneuritis associated with demyelinated plaques in the central nervous system: Report of a case. Acta Neuropathol (Berl) 1985; 67: 230–234
   PubMed Web of Science ®Google Scholar
• Amit R, Shapira Y, Blank A, et al. Acute, severe, central and peripheral nervous system combined demyelination. Pediatr Neurol 1986; 2: 47–50
   PubMedGoogle Scholar
• Amit R, Glick B, Itzchak Y, et al. Acute severe combined demyelination. Childs Nerv Syst 1992; 8: 354–356
   PubMed Web of Science ®Google Scholar
• Kinoshita A, Hayashi M, Miyamoto K, et al. Inflammatory demyelinating polyradiculitis in a patient with acute dissemi-nated encephalomyelitis (ADEM). J Neurol Neurosurg Psychiatry 1996; 60: 87–90
   PubMed Web of Science ®Google Scholar
• Okumura A, Ushida H, Maruyama K, et al. Guillain-Barre syndrome associated with central nervous system lesions. Arch Dis Child 2002; 86: 304–306
   PubMed Web of Science ®Google Scholar
• Goldschmidt B, Menonna J, Fortunato J, et al. Mycoplasma antibody in Guillain-Barre syndrome and other neurological disorders. Ann Neurol 1980; 7: 108–112
   PubMed Web of Science ®Google Scholar
• Kollet MH, West S, Davis DR, et al. Central and peripheral nervous system demyelination after infection with Mycoplasma pneumonia: Evidence of an autoimmune process. South Med J 1991; 84: 1255–1258
   PubMed Web of Science ®Google Scholar
• Nadkarni N, Lisak RP. Guillain-Barre syndrome (GBS) with bilateral optic neuritis and central white matter disease. Neurology 1993; 43: 842–843
   PubMed Web of Science ®Google Scholar
• Nishimura M, Saida T, Kuroki S, et al. Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection. J Neurol Sci 1996; 140: 91–95
   PubMed Web of Science ®Google Scholar
• Tan MJ, Chattophadyay AK, Griffiths PD, et al. Acute central and peripheral demyelination associated with Mycoplasma pneumo-niae. Pediatr Neurol 2003; 29: 239–241
   PubMed Web of Science ®Google Scholar
• Susuki K, Odaka M, Mori M, et al. Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry. Neurology 2004; 62: 949–956
   PubMed Web of Science ®Google Scholar
• Kumada S, Kusaka H, Okaniwa M, et al. Encephalomyelitis subsequent to mycoplasma infection with elevated serum anti-Gal C antibody. Pediatr Neurol 1997; 16: 241–244
   PubMed Web of Science ®Google Scholar
• Ogawara K, Kuwabara S, Mori M, et al. Axonal Guillain-Barre syndrome: Relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000; 48: 624–631
   PubMed Web of Science ®Google Scholar
• Chiba A, Kusunoki S, Shimizu T, et al. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 1992; 31: 677–679
   PubMed Web of Science ®Google Scholar
• Suzuki T, Chiba A, Kusunoki S, et al. Anti-GQ1b ganglioside antibody and ophthalmoplegia of undetermined cause. Br J Ophthalmol 1998; 82: 916–918
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Chiba A, Kanazawa I. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve 1999; 22: 1071–1074
   PubMed Web of Science ®Google Scholar
• Willison HJ, O'Hanlon GM. The immunopathogenesis of Miller Fisher syndrome. J Neuroimmunol 1999; 100: 3–12
   PubMed Web of Science ®Google Scholar
• Kornberg AL Pestronk A, Blume GM, et al. Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes. Neurology 1996; 47: 1317–1320
   PubMed Web of Science ®Google Scholar
• Odaka M, Yuki N, Yamada M, et al. Bickerstaff's brainstem encephalitis: Clinical features of 62 cases and a subgroup associated with Guillain-Barre syndrome. Brain 2003; 126: 2279–2290
   PubMed Web of Science ®Google Scholar
• Behan PO, Lessen S, Roche M. Optic neuritis in the Landry-Guillain-Barre-Strohl syndrome. Br J Ophthalmol 1976; 60: 58–59
   PubMed Web of Science ®Google Scholar
• Toshniwal P. Demyelinating optic neuropathy with Miller-Fisher syndrome. The case for overlap syndromes with central and peripheral demyelination. J Neurol 1987; 234: 353–358
   PubMed Web of Science ®Google Scholar
• Pall HS, Williams AC. Subacute polyradiculopathy with optic and auditory nerve involvement. Arch Neurol 1987; 44: 885–887
   PubMedGoogle Scholar
• Uncini A, Treviso M, Basciani M, et al. Associated central and peripheral demyelination: An electrophysiological study.] Neurol 1988; 235: 238–240
   PubMed Web of Science ®Google Scholar
• Phanthumchinda K, Intragumtornchai T, Kasantikul V. Guillain-Barre syndrome and optic neuropathy in acute leukemia. Neurology 1988; 38: 1324–1326
   PubMed Web of Science ®Google Scholar
• Carvalho AA, Galvao MD, Rocha MS, et al. [Miller fisher syndrome and optic neuritis: Case report]. Arq Neuropsiquiatr 2000; 58: 1115–1117
   PubMed Web of Science ®Google Scholar
• Colding-Jorgensen E, Vissing J. Visual impairment in anti-GQ1b positive Miller Fisher syndrome. Acta Neurol Scand 2001; 103: 259–260
   PubMed Web of Science ®Google Scholar
• Chan JW. Optic neuritis in anti-GQ1b positive recurrent Miller Fisher syndrome. Br] Ophthalmol 2003; 87: 1185–1186
   PubMed Web of Science ®Google Scholar
• Aimoto Y, Ito K, Moriwaka F, et al. Demyelinating peripheral neuropathy in Devic disease. Jpn J Psychiatry Neurol 1991; 45: 861–864
   PubMedGoogle Scholar
• Yuki N, Sato S, Tsuji S, et al. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neurol Sci 1993; 118: 83–87
   PubMed Web of Science ®Google Scholar
• Ogawara K, Kuwabara S, Yuki N. Fisher syndrome or Bickerstaff brainstem encephalitis? Anti-GQ1b IgG antibody syndrome involving both the peripheral and central nervous systems. Muscle Nerve 2002; 26: 845–849
   PubMed Web of Science ®Google Scholar
• Yuki N, Wakabayashi K, Yamada M, et al. Overlap of Guillain-Barre syndrome and Bickerstaff's brainstem encephalitis. J Neurol Sci 1997; 145: 119–121
   PubMed Web of Science ®Google Scholar
• McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China. Ann Neurol 1993; 33: 333–342
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Ogawara K, Koga M, et al. Hyperreflexia in Guillain-Barre syndrome: Relation with acute motor axonal neuropathy and anti-GM1 antibody. J Neurol Neurosurg Psychiatry 1999; 67: 180–184
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Nakata M, Sung JY, et al. Hyperreflexia in axonal Guillain-Barre syndrome subsequent to Campylobacter jejuni enteritis. J Neurol Sci 2002; 199: 89–92
   PubMed Web of Science ®Google Scholar
• Waksman BH, Adams RD. A comparative study of experimental allergic neuritis in the rabbit, guinea pig, and mouse. J Neuropathol Exp Neurol 1956; 15: 293–334
   PubMed Web of Science ®Google Scholar
• Levine S, Wenk EJ. Allergic neuritis induced in rats without the use of mycobacteria. Proc Soc Exp Biol Med 1963; 113: 898–900
   PubMed Web of Science ®Google Scholar
• Pender MP, Sears TA. Conduction block in the peripheral nervous system in experimental allergic encephalomyelitis. Nature 1982; 296: 860–862
   PubMed Web of Science ®Google Scholar
• Pender MP, Sears TA. Involvement of the dorsal root ganglion in acute experimental allergic encephalomyelitis in the Lewis rat. A histological and electrophysiological study. J Neurol Sci 1986; 72: 231–242
   PubMed Web of Science ®Google Scholar
• Stanley GP, Pender MP. The pathophysiology of chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Brain 1991; 114 (Pt 4): 1827–1853
   PubMedGoogle Scholar
• McFarlin DE, Blank SE, Kibler RF. Recurrent experimental allergic encephalomyelitis in the Lewis rat. J Immunol 1974; 113: 712–715
   PubMed Web of Science ®Google Scholar
• Chalk JB, McCombe PA, Pender MP. Conduction abnormalities are restricted to the central nervous system in experimental autoimmune encephalomyelitis induced by inoculation with proteolipid protein but not with myelin basic protein. Brain 1994; 117 (Pt 5): 975–986
   PubMedGoogle Scholar
• Chalk JB, McCombe PA, Smith R, et al. Clinical and histological findings in proteolipid protein-induced experimental autoim-mune encephalomyelitis (EAE) in the Lewis rat. Distribution of demyelination differs from that in EAE induced by other antigens. J Neurol Sci 1994; 123: 154–161
   PubMed Web of Science ®Google Scholar
• Berger T, Weerth S, Kojima K, et al. Experimental autoimmune encephalomyelitis: The antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 1997; 76: 355–364
   PubMed Web of Science ®Google Scholar
• Weerth S, Berger T, Lassmann H, et al. Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycopro-tein (MAG) in the Lewis rat. J Neuroimmunol 1999; 95: 157–164
   PubMed Web of Science ®Google Scholar
• Williams RM, Lees MB, Cambi F, et al. Chronic experimental allergic encephalomyelitis induced in rabbits with bovine white matter proteolipid apoprotein. J Neuropathol Exp Neurol 1982; 41: 508–521
   PubMed Web of Science ®Google Scholar
• Yamamura T, Namikawa T, Endoh M, et al. Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats. J Neuroimmunol 1986; 12: 143–153
   PubMed Web of Science ®Google Scholar
• Brostoff SW, Powers JM, Weise MJ. Allergic encephalomyelitis induced in guinea pigs by a peptide from the NH2-terminus of bovine P2 protein. Nature 1980; 285: 103–104
   PubMed Web of Science ®Google Scholar
• Kadlubowski M, Hughes RA. The neuritogenicity and encepha-litogenicity of P2 in the rat, guinea-pig and rabbit. J Neurol Sci 1980; 48: 171–178
   PubMedGoogle Scholar
• Saida T, Saida K, Dorfman SH, et al. Experimental allergic neuritis induced by sensitization with galactocerebroside. Science 1979; 204: 1103–1106
   PubMed Web of Science ®Google Scholar
• Saida T, Saida K, Silberberg DH, et al. Experimental allergic neuritis induced by galactocerebroside. Ann Neurol 1981; 9 Suppl: 87-101
   Google Scholar
• Raine CS, Traugott U, Farooq M, et al. Augmentation of immune-mediated demyelination by lipid haptens. Lab Invest 1981; 45: 174–182
   PubMed Web of Science ®Google Scholar
• Hoffman PM, Powers JM, Weise MJ, et al. Experimental allergic neuritis. I. Rat strain differences in the response to bovine myelin antigens. Brain Res 1980; 195: 355–362
   PubMed Web of Science ®Google Scholar
• Hayes SM, Knight KL. Group 1 CD1 genes in rabbit. J Immunol 2001; 166: 403–410
   PubMed Web of Science ®Google Scholar
• Moore GR, Traugott U, Farooq M, et al. Experimental auto-immune encephalomyelitis. Augmentation of demyelination by different myelin lipids. Lab Invest 1984; 51: 416–424
   PubMed Web of Science ®Google Scholar
• Saida T, Saida K, Silberberg DH. Demyelination produced by experimental allergic neuritis serum and anti-galactocerebroside antiserum in CNS cultures. An ultrastructural study. Acta Neuropathol (Berl) 1979; 48: 19–25
   PubMed Web of Science ®Google Scholar
• Kusunoki S, Yu RK, Kim JH. Induction of experimental autoimmune encephalomyelitis in guinea pigs using myelin basic protein and myelin glycolipids. J Neuroimmunol 1988; 18: 303–314
   PubMed Web of Science ®Google Scholar
• Van Schaik IN, Winer JB, De Haan R, et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2002; (2): CD001797
   Google Scholar
• Hommes OR, Sorensen PS, Fazekas F, et al. Intravenous immunoglobulin in secondary progressive multiple sclerosis: Randomised placebo-controlled trial. Lancet 2004; 364: 1149–1156
   PubMed Web of Science ®Google Scholar
• Fee DB, Fleming JO. Resolution of chronic inflammatory demyelinating polyneuropathy-associated central nervous system lesions after treatment with intravenous immunoglobulin. J Peripher Nerv Syst 2003; 8: 155–158
   PubMed Web of Science ®Google Scholar
• Di Trapani G, Carnevale A, Cioffi RP, et al. Multiple sclerosis associated with peripheral demyelinating neuropathy. Clin Neuropathol 1996; 15: 135–138
   PubMed Web of Science ®Google Scholar
• Krivickas LS, Hochberg FH, Freeman S. Chronic inflammatory demyelinating polyradiculoneuropathy with tumefactive central demyelination. Muscle Nerve 2006; 33: 283–288
   PubMed Web of Science ®Google Scholar
• Quan D, Pelak V, Tanabe J, et al. Spinal and cranial hypertrophic neuropathy in multiple sclerosis. Muscle Nerve 2005; 31: 772–779
   PubMed Web of Science ®Google Scholar
• Choudhary PP, Thompson N, Hughes RA. Improvement follow-ing interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 1995; 242: 252–253
   PubMed Web of Science ®Google Scholar
• Vallat JM, Hahn AF, Leger JM, et al. Interferon beta-1a as an investigational treatment for CIDP. Neurology 2003; 60: S23—S28
   Google Scholar
• Kuntzer T, Radziwil I AJ, Lettry-Trouil lat R, et al. Interferon-beta1a in chronic inflammatory demyelinating polyneuropathy. Neurology 1999; 53: 1364–1365
   PubMed Web of Science ®Google Scholar
• Hadden RD, Sharrack B, Bensa S, et al. Randomized trial of interferon beta-1 a in chronic inflammatory demyelinating poly-radiculoneuropathy. Neurology 1999; 53: 57–61
   PubMed Web of Science ®Google Scholar
• Sabatelli M, Mignogna T, Lippi G, et al. Interferon-alpha may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1995; 58: 638–639
   PubMed Web of Science ®Google Scholar
• Gorson KC, Allam G, Simovic D, et al. Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy. Neurology 1997; 48: 777–780
   PubMed Web of Science ®Google Scholar
• Gorson KC, Ropper AH, Clark BD, et al. Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a. Neurology 1998; 50: 84–87
   PubMed Web of Science ®Google Scholar
• Meriggioli MN, Rowin J. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha. Muscle Nerve 2000; 23: 433–435
   PubMed Web of Science ®Google Scholar
• Pirko I, Kuntz NL, Patterson M, et al. Contrasting effects of IFNbeta and IVIG in children with central and peripheral demyelination. Neurology 2003; 60: 1697–1699
   PubMed Web of Science ®Google Scholar
• Matsuse D, Ochi H, Tashiro K, et al. Exacerbation of chronic inflammatory demyelinating polyradiculoneuropathy during interferonbeta-1b therapy in a patient with childhood-onset multiple sclerosis. Intern Med 2005; 44: 68–72
   PubMed Web of Science ®Google Scholar
• Rotta FF, Sussman AT, Bradley WG, et al. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2000; 173: 129–139
   PubMed Web of Science ®Google Scholar